Home parenteral nutrition - An effective and safe long-term therapy for systemic sclerosis-related intestinal failure

Rheumatology

Volumn 47, Issue 2, 2008, Pages 176-179

  Brown, M ^a   Teubner, A ^b   Shaffer, J ^b   Herrick, Ariane L ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

Author keywords

Bacterial overgrowth; Home parenteral nutrition; Intestinal failure; Intestinal pseudo obstruction; Systemic sclerosis

Indexed keywords

ANTIBIOTIC AGENT; FECES LIPID; TINZAPARIN;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ARTICLE; BACTERIAL OVERGROWTH; BLOATING; CATHETER OCCLUSION; CATHETERIZATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; ENTEROPATHY; FEMALE; HUMAN; HYDROGEN BREATH TEST; MALABSORPTION; MALE; NUTRITIONAL STATUS; PARENTERAL NUTRITION; PATIENT SAFETY; PRIORITY JOURNAL; PSEUDOOBSTRUCTION; RAYNAUD PHENOMENON; RETROSPECTIVE STUDY; SYSTEMIC SCLEROSIS; THROMBOGENESIS; THROMBOSIS; TOTAL PARENTERAL NUTRITION; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; INTESTINAL DISEASES; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PARENTERAL NUTRITION, HOME; RAYNAUD DISEASE; RETROSPECTIVE STUDIES; SAFETY; SCLERODERMA, SYSTEMIC; TREATMENT OUTCOME;

EID: 38649110158     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem329     Document Type: Article

References (10)

1. Akesson A, Wollheim FA. Organ manifestations in 100 patients with progressive systemic sclerosis: A comparison between the CREST syndrome and diffuse scleroderma. Br J Rheumatol 1989;28:281-6.
2. Sjogren RW. Gastrointestinal motility disorders in scleroderma. Arthritis Rheum 1994;37:1265-82.
3. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
4. D'Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scieroderma). A study of fifty-eight autopsy cases and fifty-weight matched controls. Am J Med 1969;46:428-40.
5. Altman RD, Medsger TA, Bloch DA, Michel BA. Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 1991;34:403-13.
6. Kaye SA, Lim SG, Taylor M, Patel S, Gillespie S, Bieck CM. Small bowel bacterial overgrowth in systemic sclerosis: Detection using direct and indirect methods and treatment outcome. Br J Rheumatol 1995;34:265-9.
7. Sjogren RW. Gastrointestinal features of scleroderma. Curr Opinion Rheumatol 1996;8:569-75.
8. Ng SC, Clements PJ, Berquist WE, Furst DE, Paulus HE. Home central various hyperalimentation in fifteen patients with severe scleroderma bowel disease. Arthritis Rheum 1989;32:212-6.
9. Ishikawa M, Okada J, Kondo H. Five cases of systemic sclerosis with associated intestinal pseudo-obstruction, Ryumachi 1999;39:768-73.
10. Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000;43:2437-44.